Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Guided Therapeutics (GTHP) Work In Process (2016 - 2021)

Historic Work In Process for Guided Therapeutics (GTHP) over the last 8 years, with Q1 2021 value amounting to $80000.0.

  • Guided Therapeutics' Work In Process fell 123.46% to $80000.0 in Q1 2021 from the same period last year, while for Mar 2021 it was $80000.0, marking a year-over-year decrease of 123.46%. This contributed to the annual value of $80000.0 for FY2020, which is 123.46% down from last year.
  • According to the latest figures from Q1 2021, Guided Therapeutics' Work In Process is $80000.0, which was down 123.46% from $80000.0 recorded in Q4 2020.
  • In the past 5 years, Guided Therapeutics' Work In Process registered a high of $115000.0 during Q1 2017, and its lowest value of $80000.0 during Q3 2020.
  • Its 5-year average for Work In Process is $85000.0, with a median of $81000.0 in 2018.
  • As far as peak fluctuations go, Guided Therapeutics' Work In Process crashed by 6937.27% in 2017, and later changed by 0.0% in 2019.
  • Quarter analysis of 5 years shows Guided Therapeutics' Work In Process stood at $82000.0 in 2017, then fell by 1.22% to $81000.0 in 2018, then changed by 0.0% to $81000.0 in 2019, then dropped by 1.23% to $80000.0 in 2020, then changed by 0.0% to $80000.0 in 2021.
  • Its last three reported values are $80000.0 in Q1 2021, $80000.0 for Q4 2020, and $80000.0 during Q3 2020.